Entity Common Stock, Shares Outstanding of Drugs Made In America Acquisition II Corp. for 18 Nov 2025

Taxonomy & unit: dei: shares
Description: Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary: Drugs Made In America Acquisition II Corp. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate for 18 Nov 2025.
Drugs Made In America Acquisition II Corp. Entity Common Stock, Shares Outstanding for the quarter ending 18 Nov 2025 was 65,575,000.
Source SEC data: View on sec.gov

Entity Common Stock, Shares Outstanding, Quarterly (shares)

Drugs Made In America Acquisition II Corp. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	65,575,000			18 Nov 2025	10-Q	18 Nov 2025	2025	Q3

* An asterisk sign (*) next to the value indicates that the value is likely invalid.